USD 14.31
(-0.43%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 81.13 Million USD | 1.69% |
2022 | 79.78 Million USD | -3.37% |
2021 | 82.56 Million USD | -10.85% |
2020 | 92.61 Million USD | -4.32% |
2019 | 96.79 Million USD | -4.49% |
2018 | 101.34 Million USD | 20.33% |
2017 | 84.21 Million USD | -11.04% |
2016 | 94.66 Million USD | -5.14% |
2015 | 99.79 Million USD | 4843.06% |
2014 | -2.1 Million USD | -340.73% |
2013 | 874 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 21.82 Million USD | 75.66% |
2024 Q2 | 23.24 Million USD | -630.51% |
2023 Q2 | 22.14 Million USD | 0.36% |
2023 Q4 | 16.9 Million USD | -17.42% |
2023 FY | - USD | 1.69% |
2023 Q3 | 20.46 Million USD | -7.59% |
2023 Q1 | 22.06 Million USD | 22.06% |
2022 Q4 | 18.08 Million USD | -16.73% |
2022 FY | - USD | -3.37% |
2022 Q3 | 21.71 Million USD | 3.96% |
2022 Q2 | 20.88 Million USD | 7.9% |
2022 Q1 | 19.35 Million USD | 0.76% |
2021 Q2 | 21.13 Million USD | -4.78% |
2021 Q4 | 19.2 Million USD | -4.07% |
2021 FY | - USD | -10.85% |
2021 Q1 | 22.19 Million USD | 25.78% |
2021 Q3 | 20.02 Million USD | -5.27% |
2020 Q3 | 25.02 Million USD | 3.2% |
2020 Q1 | 25.75 Million USD | 19.57% |
2020 Q4 | 17.64 Million USD | -29.47% |
2020 FY | - USD | -4.32% |
2020 Q2 | 24.24 Million USD | -5.86% |
2019 Q4 | 21.54 Million USD | -10.56% |
2019 Q1 | 23.78 Million USD | -10.77% |
2019 Q2 | 27.34 Million USD | 14.96% |
2019 Q3 | 24.08 Million USD | -11.92% |
2019 FY | - USD | -4.49% |
2018 Q4 | 26.65 Million USD | 28.71% |
2018 FY | - USD | 20.33% |
2018 Q3 | 20.71 Million USD | -22.67% |
2018 Q2 | 26.78 Million USD | -0.31% |
2018 Q1 | 26.86 Million USD | 22.28% |
2017 Q2 | 20.68 Million USD | 4.36% |
2017 FY | - USD | -11.04% |
2017 Q1 | 19.81 Million USD | 3.23% |
2017 Q4 | 21.97 Million USD | 1.05% |
2017 Q3 | 21.74 Million USD | 5.12% |
2016 FY | - USD | -5.14% |
2016 Q2 | 25.33 Million USD | -8.07% |
2016 Q3 | 22.58 Million USD | -10.84% |
2016 Q1 | 27.55 Million USD | 46.56% |
2016 Q4 | 19.19 Million USD | -14.99% |
2015 Q2 | 21.67 Million USD | -13.51% |
2015 Q4 | 18.8 Million USD | -7.67% |
2015 Q3 | 20.36 Million USD | -6.06% |
2015 Q1 | 25.06 Million USD | 148.12% |
2015 FY | - USD | 4843.06% |
2014 Q1 | 292 Thousand USD | -71.81% |
2014 Q2 | -1.02 Million USD | -450.0% |
2014 Q4 | 10.1 Million USD | 188.03% |
2014 Q3 | -11.47 Million USD | -1022.8% |
2014 FY | - USD | -340.73% |
2013 Q3 | -15 Thousand USD | 86.11% |
2013 FY | - USD | 0.0% |
2013 Q1 | -47 Thousand USD | 0.0% |
2013 Q2 | -108 Thousand USD | -129.79% |
2013 Q4 | 1.03 Million USD | 7006.67% |
2012 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Diversified Healthcare Trust | 207.29 Million USD | 60.859% |
Diversified Healthcare Trust | 207.29 Million USD | 60.859% |
Healthcare Trust, Inc. | 81.13 Million USD | 0.0% |
Sabra Health Care REIT, Inc. | 418.15 Million USD | 80.596% |